Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Daniel Vasella

  1. The Vaccine Renaissance: How Big Pharma Profits from Swine Flu
    Spiegel Online logo Spiegel Online 5 days ago
    The Novartis swine flu vaccine Celtura

    Once spurned by drugmakers as low-margin and risky, vaccines to fight diseases such as H1N1 are now a growing business for Novartis and others. Full Article at Spiegel Online

  2. Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
    World Pharma News logo World Pharma News 6 days ago

    Today, Novartis officially inaugurated the US's first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina. Full Article at World Pharma News

  3. AP Photo logo AP Photo 10 months ago
    Swiss Daniel Vasella, right, Chairman and CEO of Novartis, Switzerland, speaks while Rex Tillerson from the U.S. , Chaiman and CEO of ExxonMobil Corporation, USA, sits next to him during the World Economic Forum in Davos, Switzerland on Saturday, Jan....

    Swiss Daniel Vasella, right, Chairman and CEO of Novartis, Switzerland, speaks while Rex Tillerson from the U.S. , Chaiman and CEO of ExxonMobil Corporation, USA, sits next to him during the World Economic Forum in Davos, Switzerland on Saturday, Jan.... View Photo »

  4. We are proud to be one of the first companies to bring influenza cell culture as well as adjuvant technology to the United States
    – Daniel Vasella SOURCE: PR-Inside.com 6 days ago
  5. Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
    Drugs.com logo Drugs.com 6 days ago

    * Total investment of nearly USD 1 billion through a partnership between Novartis and the US Department of Health and Human Services * Inauguration marks important milestone in using modern biotechnologies for flu vaccine production to replace the... Full Article at Drugs.com

  6. 'Corporations need to work with govt'
    Times of India logo Times of India 1 week ago

    Almost a decade into the 21st century, the modern corporation stands shaken and humbled. For the millions of investors around the world who’ve lost trillions of dollars, their faith in capitalism has been rudely challenged. Full Article at Times of India

  7. Novartis CEO on the Swine Flu Vaccine, Future of Pharma
    FOX Business logo FOX Business 1 week ago

    In another First on FOX Business interview, I had the chance to sit down with Dr. Daniel Vasella, CEO of Novartis. Full Article at FOX Business

  8. Reuters Pictures 10 months ago
    CEO of Swiss drugmaker Novartis Daniel Vasella (R) addresses the annual news conference in Basel January 28, 2009.

    CEO of Swiss drugmaker Novartis Daniel Vasella (R) addresses the annual news conference in Basel January 28, 2009. View Photo »

  9. A fact that stands out for me – and one that's left a bitter taste – is that the government is working so closely with Daniel Vasella [CEO of Novartis]
    SOURCE: Swissinfo 2 weeks ago
  10. Novartis 4Q Profit Almost Doubles; Novartis Expects "Record Results" In 2009
    YouTube Logo YouTube Videos 10 months ago
  11. Big Pharma execs top highest-paid Swiss list
    FiercePharma 2 weeks ago

    Who tops the list of highest-paid Swiss executives? None other than pharma's own Daniel Vasella (photo), CEO of Novartis. Vasella's 2008 compensation grew by more than 20 percent from 2007, to 20.5 million francs. Full Article at FiercePharma

  12. Novartis puts R&D activities in India on hold
    Times of India logo Times of India 2 weeks ago

    MUMBAI: Frustrated with patent challenges, Swiss-pharma giant Novartis has put its research and development (R&D) activities in India on the back burner, its CEO Daniel Vasella said. Full Article at Times of India

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

About Daniel Vasella

Wikipedia

There are no results for this module. Edit this module to change the search term used to query Wikipedia

Related Photos

CEO of Swiss drugmaker Novartis Daniel Vasella (R) addresses the annual news conference in Basel January 28, 2009. Novartis's fourth-quarter net profit rose 62 percent to $1.5 billion, driven by sales of blood pressure and cancer drugs, but missed forecasts as the strong dollar weighed.
Pause Play 1/25
prev
  1. Swiss Daniel Vasella, right, Chairman and CEO of Novartis, Switzerland, speaks while Rex Tillerson from the U.S. , Chaiman and CEO of ExxonMobil Corporation, USA, sits next to him during the World Economic Forum in Davos, Switzerland on Saturday, Jan. 31, 2009. AP Photo logo AP Photo 10 months ago

    Swiss Daniel Vasella, right, Chairman and CEO of Novartis, Switzerland, speaks while Rex Tillerson from the U.S. , Chaiman and CEO of ExxonMobil Corporation, USA, sits next to him during the World Economic Forum in Davos, Switzerland on Saturday, Jan. 31, 2009.

    View Photo »
  2. CEO of Swiss drugmaker Novartis Daniel Vasella (R) addresses the annual news conference in Basel January 28, 2009. Novartis's fourth-quarter net profit rose 62 percent to $1.5 billion, driven by sales of blood pressure and cancer drugs, but missed forecasts as the strong dollar weighed. Reuters Pictures 10 months ago

    CEO of Swiss drugmaker Novartis Daniel Vasella (R) addresses the annual news conference in Basel January 28, 2009. Novartis's fourth-quarter net profit rose 62 percent to $1.5 billion, driven by sales of blood pressure and cancer drugs, but missed forecasts as the strong dollar weighed.

    View Photo »
  3. CEO of Swiss drugmaker Novartis Daniel Vasella arrives for the annual news conference in Basel January 28, 2009. Novartis's fourth-quarter net profit rose 62 percent to $1.5 billion, driven by sales of blood pressure and cancer drugs, but missed forecasts as the strong dollar weighed. Reuters Pictures 10 months ago

    CEO of Swiss drugmaker Novartis Daniel Vasella arrives for the annual news conference in Basel January 28, 2009. Novartis's fourth-quarter net profit rose 62 percent to $1.5 billion, driven by sales of blood pressure and cancer drugs, but missed forecasts as the strong dollar weighed.

    View Photo »
  4. Swiss pharmaceuticals giant Novartis CEO and President Daniel Vasella (R) discusses with the COO Joerg Reinhardt (L) during the annual media conference 28 January 2009 in Basel. Getty Images logo Getty Images 10 months ago

    Swiss pharmaceuticals giant Novartis CEO and President Daniel Vasella (R) discusses with the COO Joerg Reinhardt (L) during the annual media conference 28 January 2009 in Basel.

    View Photo »
  5. Daniel Vasella, CEO of Swiss pharmaceutical group Novartis, is projected on a screen as he speaks during the general assembly of Novartis in Basel, Switzerland, Tuesday, Feb. 24, 2009. AP Photo logo AP Photo 9 months ago

    Daniel Vasella, CEO of Swiss pharmaceutical group Novartis, is projected on a screen as he speaks during the general assembly of Novartis in Basel, Switzerland, Tuesday, Feb. 24, 2009.

    View Photo »
  6. Swiss Daniel Vasella, Chairman and CEO of Novartis, Switzerland speaks during the World Economic Forum in Davos, Switzerland on Saturday, Jan. 31, 2009. AP Photo logo AP Photo 10 months ago

    Swiss Daniel Vasella, Chairman and CEO of Novartis, Switzerland speaks during the World Economic Forum in Davos, Switzerland on Saturday, Jan. 31, 2009.

    View Photo »
  7. Swiss Daniel Vasella, Chairman and CEO Chairman and CEO of Novartis, Switzerland, during the World Economic Forum in Davos, Switzerland on Saturday, Jan. 31, 2009. AP Photo logo AP Photo 10 months ago

    Swiss Daniel Vasella, Chairman and CEO Chairman and CEO of Novartis, Switzerland, during the World Economic Forum in Davos, Switzerland on Saturday, Jan. 31, 2009.

    View Photo »
  8. Daniel Vasella, Chairman and Chief Executive Officer, Novartis attends "Completing the Malaria Mission" session at the World Economic Forum (WEF) in Davos January 31, 2009. Reuters Pictures 10 months ago

    Daniel Vasella, Chairman and Chief Executive Officer, Novartis attends "Completing the Malaria Mission" session at the World Economic Forum (WEF) in Davos January 31, 2009.

    View Photo »
  9. Daniel Vasella, Chairman and Chief Executive Officer, Novartis attends "Completing the Malaria Mission" session at the World Economic Forum (WEF) in Davos January 31, 2009. Reuters Pictures 10 months ago

    Daniel Vasella, Chairman and Chief Executive Officer, Novartis attends "Completing the Malaria Mission" session at the World Economic Forum (WEF) in Davos January 31, 2009.

    View Photo »
  10. Daniel Vasella, CEO Novartis, left, smiles next to Raymund Breu, Chief Financial Officer, right, during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009. AP Photo logo AP Photo 10 months ago

    Daniel Vasella, CEO Novartis, left, smiles next to Raymund Breu, Chief Financial Officer, right, during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009.

    View Photo »
  11. Daniel Vasella, CEO of Novartis, speaks to the media during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009. AP Photo logo AP Photo 10 months ago

    Daniel Vasella, CEO of Novartis, speaks to the media during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009.

    View Photo »
  12. Daniel Vasella, CEO of Novartis, speaks to the media during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009. AP Photo logo AP Photo 10 months ago

    Daniel Vasella, CEO of Novartis, speaks to the media during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009.

    View Photo »
  13. Daniel Vasella, CEO of Novartis, speaks during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009. AP Photo logo AP Photo 10 months ago

    Daniel Vasella, CEO of Novartis, speaks during the 2008 full-year results press conference in Basel, Switzerland, Wednesday, Jan. 28, 2009.

    View Photo »
  14. U.S. Secretary of Health and Human Services Kathleen Sebelius (L-R), HHS Assistant Secretary for Preparedness and Response Dr. Nicole Lurie, Novartis CEO and Chairman Daniel Vasella, North Carolina Governor Bev Perdue and North Carolina Commerce Secretary Keith Crisco tour the new Novar... Reuters Pictures 6 days ago

    U.S. Secretary of Health and Human Services Kathleen Sebelius (L-R), HHS Assistant Secretary for Preparedness and Response Dr. Nicole Lurie, Novartis CEO and Chairman Daniel Vasella, North Carolina Governor Bev Perdue and North Carolina Commerce Secretary Keith Crisco tour the new Novar...

    View Photo »
  15. Chairman and CEO of Novartis AG Daniel Vasella (R) talks next to Chairman of Aetna, Inc. Ronald A. Williams (L) at Wall Street Journal CEO Council meeting on rebuilding global prosperity in Washington, November 17, 2009. Reuters Pictures 1 week ago

    Chairman and CEO of Novartis AG Daniel Vasella (R) talks next to Chairman of Aetna, Inc. Ronald A. Williams (L) at Wall Street Journal CEO Council meeting on rebuilding global prosperity in Washington, November 17, 2009.

    View Photo »
  16. Chairman and CEO of Novartis AG Daniel Vasella at Wall Street Journal CEO Council meeting on rebuilding global prosperity in Washington, November 17, 2009. Reuters Pictures 1 week ago

    Chairman and CEO of Novartis AG Daniel Vasella at Wall Street Journal CEO Council meeting on rebuilding global prosperity in Washington, November 17, 2009.

    View Photo »
  17. A picture taken on February 26, 2008 shows the chairman and CEO of Novartis, Daniel Vasella, behind a logo of the Swiss drugs giant during a shareholders meeting in Basel. Getty Images logo Getty Images 6 months ago

    A picture taken on February 26, 2008 shows the chairman and CEO of Novartis, Daniel Vasella, behind a logo of the Swiss drugs giant during a shareholders meeting in Basel.

    View Photo »
  18. Swiss drugmaker Novartis Chief Financial Officer (CFO) Raymond Breu (L) stands next to Chief Executive Officer (CEO) Daniel Vasella as he addresses the annual general shareholders meeting in Basel February 24, 2009. Reuters Pictures 9 months ago

    Swiss drugmaker Novartis Chief Financial Officer (CFO) Raymond Breu (L) stands next to Chief Executive Officer (CEO) Daniel Vasella as he addresses the annual general shareholders meeting in Basel February 24, 2009.

    View Photo »
  19. Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella is pictured on a giant screen as he addresses the annual general shareholders meeting in Basel February 24, 2009. Reuters Pictures 9 months ago

    Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella is pictured on a giant screen as he addresses the annual general shareholders meeting in Basel February 24, 2009.

    View Photo »
  20. Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella is pictured on a giant screen as he addresses the annual general shareholders meeting in Basel February 24, 2009. Reuters Pictures 9 months ago

    Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella is pictured on a giant screen as he addresses the annual general shareholders meeting in Basel February 24, 2009.

    View Photo »
  21. Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella addresses the annual general shareholders meeting in Basel February 24, 2009. Reuters Pictures 9 months ago

    Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella addresses the annual general shareholders meeting in Basel February 24, 2009.

    View Photo »
  22. Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella addresses the annual general shareholders meeting in Basel February 24, 2009. Reuters Pictures 9 months ago

    Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella addresses the annual general shareholders meeting in Basel February 24, 2009.

    View Photo »
  23. Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella addresses the annual general shareholders meeting in Basel February 24, 2009. Reuters Pictures 9 months ago

    Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella addresses the annual general shareholders meeting in Basel February 24, 2009.

    View Photo »
  24. Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella addresses the annual general shareholders meeting in Basel February 24, 2009. Reuters Pictures 9 months ago

    Swiss drugmaker Novartis Chief Executive Officer (CEO) Daniel Vasella addresses the annual general shareholders meeting in Basel February 24, 2009.

    View Photo »
  25. CEO of Swiss drugmaker Novartis Daniel Vasella leaves after the annual news conference in Basel January 28, 2009. Novartis's fourth-quarter net profit rose 62 percent to $1.5 billion, driven by sales of blood pressure and cancer drugs, but missed forecasts as the strong dollar weighed. Reuters Pictures 10 months ago

    CEO of Swiss drugmaker Novartis Daniel Vasella leaves after the annual news conference in Basel January 28, 2009. Novartis's fourth-quarter net profit rose 62 percent to $1.5 billion, driven by sales of blood pressure and cancer drugs, but missed forecasts as the strong dollar weighed.

    View Photo »
next
Reuters Pictures 10 months ago

CEO of Swiss drugmaker Novartis Daniel Vasella (R) addresses the annual news conference in Basel January 28, 2009. Novartis's fourth-quarter net profit rose 62 percent to $1.5 billion, driven by sales of blood pressure and cancer drugs, but missed forecasts as the strong dollar weighed.

View Photo »
View All »

Related Topics

  1. Novartis Novartis
  2. Swine Flu Swine Flu
  3. H1N1 H1N1
  4. High Blood Pressure
  5. US Food and Drug Administration
  6. CNBC CNBC

Timeline of Coverage

  1. Click to see all coverage from Oct 14, 2009
    0
    October 14, 2009
  2. Click to see all coverage from Oct 15, 2009
    0
    October 15, 2009
  3. Click to see all coverage from Oct 16, 2009
    1
    October 16, 2009
  4. Click to see all coverage from Oct 17, 2009
    1
    October 17, 2009
  5. Click to see all coverage from Oct 18, 2009
    0
    October 18, 2009
  6. Click to see all coverage from Oct 19, 2009
    0
    October 19, 2009
  7. Click to see all coverage from Oct 20, 2009
    0
    October 20, 2009
  8. Click to see all coverage from Oct 21, 2009
    0
    October 21, 2009
  9. Click to see all coverage from Oct 22, 2009
    17
    October 22, 2009
  10. Click to see all coverage from Oct 23, 2009
    2
    October 23, 2009
  11. Click to see all coverage from Oct 24, 2009
    0
    October 24, 2009
  12. Click to see all coverage from Oct 25, 2009
    1
    October 25, 2009
  13. Click to see all coverage from Oct 26, 2009
    1
    October 26, 2009
  14. Click to see all coverage from Oct 27, 2009
    0
    October 27, 2009
  15. Click to see all coverage from Oct 28, 2009
    0
    October 28, 2009
  16. Click to see all coverage from Oct 29, 2009
    0
    October 29, 2009
  17. Click to see all coverage from Oct 30, 2009
    0
    October 30, 2009
  18. Click to see all coverage from Oct 31, 2009
    0
    October 31, 2009
  19. Click to see all coverage from Nov 01, 2009
    0
    November 01, 2009
  20. Click to see all coverage from Nov 02, 2009
    0
    November 02, 2009
  21. Click to see all coverage from Nov 03, 2009
    7
    November 03, 2009
  22. Click to see all coverage from Nov 04, 2009
    7
    November 04, 2009
  23. Click to see all coverage from Nov 05, 2009
    0
    November 05, 2009
  24. Click to see all coverage from Nov 06, 2009
    1
    November 06, 2009
  25. Click to see all coverage from Nov 07, 2009
    0
    November 07, 2009
  26. Click to see all coverage from Nov 08, 2009
    0
    November 08, 2009
  27. Click to see all coverage from Nov 09, 2009
    0
    November 09, 2009
  28. Click to see all coverage from Nov 10, 2009
    1
    November 10, 2009
  29. Click to see all coverage from Nov 11, 2009
    4
    November 11, 2009
  30. Click to see all coverage from Nov 12, 2009
    3
    November 12, 2009
  31. Click to see all coverage from Nov 13, 2009
    0
    November 13, 2009
  32. Click to see all coverage from Nov 14, 2009
    0
    November 14, 2009
  33. Click to see all coverage from Nov 15, 2009
    0
    November 15, 2009
  34. Click to see all coverage from Nov 16, 2009
    0
    November 16, 2009
  35. Click to see all coverage from Nov 17, 2009
    0
    November 17, 2009
  36. Click to see all coverage from Nov 18, 2009
    1
    November 18, 2009
  37. Click to see all coverage from Nov 19, 2009
    0
    November 19, 2009
  38. Click to see all coverage from Nov 20, 2009
    0
    November 20, 2009
  39. Click to see all coverage from Nov 21, 2009
    0
    November 21, 2009
  40. Click to see all coverage from Nov 22, 2009
    1
    November 22, 2009
  41. Click to see all coverage from Nov 23, 2009
    2
    November 23, 2009
  42. Click to see all coverage from Nov 24, 2009
    7
    November 24, 2009
  43. Click to see all coverage from Nov 25, 2009
    1
    November 25, 2009
  44. Click to see all coverage from Nov 26, 2009
    0
    November 26, 2009
  45. Click to see all coverage from Nov 27, 2009
    0
    November 27, 2009
  46. Click to see all coverage from Nov 28, 2009
    0
    November 28, 2009
  47. Click to see all coverage from Nov 29, 2009
    0
    November 29, 2009
  48. Click to see all coverage from Nov 30, 2009
    0
    November 30, 2009

Related Videos

  1. YouTube
  2. Videosurf
  3. Truveo
  1. Loading video...
    1. Watch video
      Novartis CEO Daniel L. Vasella MD
      5 months ago
    2. Watch video
      Novartis 4Q Profit Almost Doubles; Novartis Exp...
      10 months ago
    3. Watch video
      Davos Annual Meeting 2005 - Gerhard Schröder
      27 months ago
    4. Watch video
      SCHWEINEGRIPPE Verarschung Daniel Vasella CEO N...
      2 months ago
    5. Watch video
      Davos Annual Meeting 2009 - Completing the Mala...
      10 months ago
    6. Watch video
      Davos Annual Meeting 2006 - Guiding Principles...
      3 months ago
    View All YouTube Videos »
    1. Watch video
      Encounter with Daniel Vasella.mp4
      1 week ago
    2. Watch video
      India not growing in drug discovery space: Dani...
      1 week ago
    3. Watch video
      Novartis CEO on Earnings
      10 months ago
    4. Watch video
      SCHWEINEGRIPPE SONG Daniel Vasella CEO Novartis...
      2 months ago
    5. Watch video
      Rasmussen, Profumo, Vasella at Davos: Roving Ca...
      10 months ago
    6. Watch video
      Celling Flu Vaccines
      1 week ago
    View All Videosurf Videos »
  3. Powered by Truveo
    1. Watch video
      Celling Flu Vaccines
      6 days ago
    2. Watch video
      CEOs Grade the House Health-Care Bill
      1 week ago
    3. Watch video
      Davos 2007: Daniel Vasella
      15 months ago
    4. Watch video
      Novartis CEO Speaks Out About Arsonist Attack
      3 months ago
    5. Watch video
      Reinventing R and D at Novartis-How Novartis CE...
      5 months ago
    6. Watch video
      CEO Council Priorities: Health
      12 months ago
    View All Truveo Videos »

Related Quotes

  • Previous
  • Next
  • 1/4
  1. We are proud to be one of the first companies to bring influenza cell culture as well as adjuvant technology to the United States
    – Daniel Vasella SOURCE: PR-Inside.com 6 days ago
  2. A fact that stands out for me – and one that's left a bitter taste – is that the government is working so closely with Daniel Vasella [CEO of Novartis]
    SOURCE: Swissinfo 2 weeks ago
  3. In principle you can discover in India, you can do research. There has been some progress on the protection of intellectual property but its not up to the standard that I would expect to make an investment into discovery led research
    – Daniel Vasella SOURCE: Biospace 2 weeks ago
  4. We are confident that our expanded investment in R&D will result in innovative therapies for patients in China and other countries nurtured by the growing scientific excellence in China.
    – Daniel Vasella SOURCE: PR-Inside.com 3 weeks ago
View All »